Abstract
Globally, about 1% of pregnant women are persistently infected with the hepatitis C virus (HCV)1. Mother-to-child transmission of HCV occurs in 3–5% of pregnancies2 and accounts for most new childhood infections1,3. HCV-specific CD8+ cytotoxic T lymphocytes (CTLs) are vital in the clearance of acute HCV infections4,5,6, but in the 60–80% of infections that persist, these cells become functionally exhausted or select for mutant viruses that escape T cell recognition7,8,9. Increased HCV replication during pregnancy10,11 suggests that maternofetal immune tolerance mechanisms12 may further impair HCV-specific CTLs, limiting their selective pressure on persistent viruses. To assess this possibility, we characterized circulating viral quasispecies during and after consecutive pregnancies in two women. This revealed a loss of some escape mutations in HLA class I epitopes during pregnancy that was associated with emergence of more fit viruses13. CTL selective pressure was reimposed after childbirth, at which point escape mutations in these epitopes again predominated in the quasispecies and viral load dropped sharply14. Importantly, the viruses transmitted perinatally were those with enhanced fitness due to reversion of escape mutations. Our findings indicate that the immunoregulatory changes of pregnancy reduce CTL selective pressure on HCV class I epitopes, thereby facilitating vertical transmission of viruses with optimized replicative fitness.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
30 May 2014
In the version of this article initially published, the K1398R/A1409T variant of the 1395–1410 amino acid sequence was erroneously depicted with an arginine in position 1397 in Figure 3a. The correct depiction of the K1398R/A1409T variant should have arginine in position 1398. The error has been corrected in the HTML and PDF versions of the article.
References
Arshad, M., El-Kamary, S.S. & Jhaveri, R. Hepatitis C virus infection during pregnancy and the newborn period—are they opportunities for treatment? J. Viral Hepat. 18, 229–236 (2011).
Mast, E.E. et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J. Infect. Dis. 192, 1880–1889 (2005).
Bortolotti, F. et al. Epidemiological profile of 806 Italian children with hepatitis C virus infection over a 15-year period. J. Hepatol. 46, 783–790 (2007).
Shoukry, N.H. et al. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J. Exp. Med. 197, 1645–1655 (2003).
Thimme, R. et al. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194, 1395–1406 (2001).
Lechner, F. et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191, 1499–1512 (2000).
Cox, A.L. et al. Cellular immune selection with hepatitis C virus persistence in humans. J. Exp. Med. 201, 1741–1752 (2005).
Rehermann, B. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J. Clin. Invest. 119, 1745–1754 (2009).
Bowen, D.G. & Walker, C.M. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436, 946–952 (2005).
Gervais, A. et al. Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J. Hepatol. 32, 293–299 (2000).
Wejstål, R., Widell, A. & Norkrans, G. HCV-RNA levels increase during pregnancy in women with chronic hepatitis C. Scand. J. Infect. Dis. 30, 111–113 (1998).
Guleria, I. & Sayegh, M.H. Maternal acceptance of the fetus: true human tolerance. J. Immunol. 178, 3345–3351 (2007).
Salloum, S. et al. Escape from HLA-B*08–restricted CD8 T cells by hepatitis C virus is associated with fitness costs. J. Virol. 82, 11803–11812 (2008).
Lin, H.H. & Kao, J.H. Hepatitis C virus load during pregnancy and puerperium. BJOG 107, 1503–1506 (2000).
Callendret, B. et al. Transmission of clonal hepatitis C virus genomes reveals the dominant but transitory role of CD8+ T cells in early viral evolution. J. Virol. 85, 11833–11845 (2011).
Koziel, M.J. et al. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J. Virol. 67, 7522–7532 (1993).
Mateu, G., Donis, R.O., Wakita, T., Bukh, J. & Grakoui, A. Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death. Virology 376, 397–407 (2008).
Kuiken, C. et al. A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes. Hepatology 44, 1355–1361 (2006).
Rothwangl, K.B., Manicassamy, B., Uprichard, S.L. & Rong, L. Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding. Virol. J. 5, 46 (2008).
Timm, J. et al. CD8 epitope escape and reversion in acute HCV infection. J. Exp. Med. 200, 1593–1604 (2004).
Dittmar, K.A., Goodenbour, J.M. & Pan, T. Tissue-specific differences in human transfer RNA expression. PLoS Genet. 2, e221 (2006).
Shimakami, T. et al. Protease inhibitor-resistant hepatitis C virus mutants with reduced fitness from impaired production of infectious virus. Gastroenterology 140, 667–675 (2011).
Ma, Y., Yates, J., Liang, Y., Lemon, S.M. & Yi, M. NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly. J. Virol. 82, 7624–7639 (2008).
Ruhl, M. et al. CD8+ T-cell response promotes evolution of hepatitis C virus nonstructural proteins. Gastroenterology 140, 2064–2073 (2011).
Yusim, K. et al. Los alamos hepatitis C immunology database. Appl. Bioinformatics 4, 217–225 (2005).
Ruhl, M. et al. Escape from a dominant HLA-B*15–restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope. J. Virol. 86, 991–1000 (2012).
Mok, J., Pembrey, L., Tovo, P.A. & Newell, M.L. When does mother to child transmission of hepatitis C virus occur? Arch. Dis. Child. Fetal Neonatal Ed. 90, F156–F160 (2005).
Thobakgale, C.F. et al. Impact of HLA in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection. J. Virol. 83, 10234–10244 (2009).
Ray, S.C. et al. Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J. Exp. Med. 201, 1753–1759 (2005).
Timm, J. et al. Human leukocyte antigen–associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution. Hepatology 46, 339–349 (2007).
Dal Molin, G. et al. Mother-to-infant transmission of hepatitis C virus: rate of infection and assessment of viral load and IgM anti-HCV as risk factors. J. Med. Virol. 67, 137–142 (2002).
Aluvihare, V.R., Kallikourdis, M. & Betz, A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5, 266–271 (2004).
Wang, C. et al. Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin-17 production via programmed death 1. Immunology 126, 329–335 (2009).
Polanczyk, M.J., Hopke, C., Vandenbark, A.A. & Offner, H. Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J. Neurosci. Res. 84, 370–378 (2006).
Alegre, E. et al. Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy. Hum. Immunol. 68, 661–667 (2007).
Bigger, C.B. et al. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J. Virol. 78, 13779–13792 (2004).
Larrea, E. et al. Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection. J. Virol. 81, 3662–3666 (2007).
Munn, D.H. et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281, 1191–1193 (1998).
Kasprowicz, V. et al. Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution. J. Virol. 84, 1656–1663 (2010).
ter Borg, M.J., Leemans, W.F., de Man, R.A. & Janssen, H.L. Exacerbation of chronic hepatitis B infection after delivery. J. Viral Hepat. 15, 37–41 (2008).
Saitou, N. & Nei, M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4, 406–425 (1987).
Edgar, R.C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792–1797 (2004).
Nei, M. & Kumar, S. Molecular Evolution and Phylogenetics (Oxford University Press, New York, 2000).
Tamura, K. et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28, 2731–2739 (2011).
Vita, R. et al. The immune epitope database 2.0. Nucleic Acids Res. 38, D854–D862 (2010).
Rauch, A. et al. Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure. Hepatology 50, 1017–1029 (2009).
Peters, B. & Sette, A. Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics 6, 132 (2005).
Kimura, Y., Gushima, T., Rawale, S., Kaumaya, P. & Walker, C.M. Escape mutations alter proteasome processing of major histocompatibility complex class I–restricted epitopes in persistent hepatitis C virus infection. J. Virol. 79, 4870–4876 (2005).
Wakita, T. et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11, 791–796 (2005).
Blight, K.J., McKeating, J.A. & Rice, C.M. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76, 13001–13014 (2002).
Uebelhoer, L. et al. Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness. PLoS Pathog. 4, e1000143 (2008).
Acknowledgements
We thank J. Hunkler for coordination of the project at The Ohio State University STEPP Clinic and the Nationwide Children's Hospital FACES Clinic. The assistance of C. Potter of the Nationwide Children's Hospital Division of Gastroenterology and G. Mateu of the Emory Vaccine Center is also gratefully acknowledged. We especially thank the subjects and their families for their participation in this study. This work was supported by the US National Institutes of Health (R37-AI47367 to C.M.W., R56-AI096882 and R01-AI096882 to C.M.W. and J.R.H., RO1-DA024565 and R01-AI95690 to S.M.L., R01-AI070101 and R01-DK083356 to A.G., T32-HD043003 and K12-HD043372 to J.R.H., and the Yerkes Research Center Base Grant P51RR-000165 (A.G.)), the Research Institute at Nationwide Children's Hospital (C.M.W. and J.R.H.), and the University of North Carolina University Cancer Research Fund (S.M.L.).
Author information
Authors and Affiliations
Contributions
J.R.H. and C.M.W. conceived of the study; M.R.P. and J.R.H. developed the patient cohort; J.R.H. and J.A.K. designed and conducted T cell experiments and sequenced viral genomes; S.K., A.A.P. and K.L.M. built constructs and conducted viral fitness assays, which A.G. and S.M.L. supervised; J.R.H. wrote the manuscript with editorial input from the other authors.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–3 and Supplementary Table 1 (PDF 153 kb)
Rights and permissions
About this article
Cite this article
Honegger, J., Kim, S., Price, A. et al. Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses. Nat Med 19, 1529–1533 (2013). https://doi.org/10.1038/nm.3351
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3351
This article is cited by
-
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Nature Communications (2023)
-
Testing for Hepatitis C in Pregnancy: the Time Has Come for Routine Rather than Risk-Based
Current Hepatology Reports (2019)
-
Identification of the core regulators of the HLA I-peptide binding process
Scientific Reports (2017)
-
Quasispecies of Hepatitis C Virus Participate in Cell-Specific Infectivity
Scientific Reports (2017)
-
The role of HCV proteins on treatment outcomes
Virology Journal (2015)